Quantcast
Last updated on April 21, 2014 at 9:27 EDT

Latest Insulin pen Stories

2012-01-19 08:15:00

PRINCETON, N.J., Jan. 19, 2012 /PRNewswire/ -- Novo Nordisk (NYSE: NVO), the world leader in diabetes care, has been ranked 43rd in FORTUNE magazine's 2012 "100 Best Companies to Work For" list. Reflecting the passion of Novo Nordisk's employees, the company has been highlighted on the list for four consecutive years. (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO ) "I'm convinced that it is our people who set us apart. Each and every person at Novo Nordisk...

2011-12-19 04:55:00

DUSSELDORF, Germany, December 19, 2011 /PRNewswire/ -- - Growth in demand for pharmaceutical and medical plastic systems - Gerresheimer invests around EUR 25 million in its Pfreimd plant - 130 new jobs Gerresheimer AG, one of the world's leading suppliers to the pharma and healthcare industry, further invests in the growth market of complex plastic systems for pharmaceutical and medical applications. Production capacity is being...

2011-11-15 09:00:00

PRINCETON, N.J. and INDIANAPOLIS, Ind., Nov. 15, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and Chip Ganassi Racing Teams, Inc. announced today that the two organizations have entered into a multi-year extension of their partnership. Novo Nordisk will remain the primary sponsor of the No. 83 Novo Nordisk Chip Ganassi Racing entry, driven by Charlie Kimball in the IZOD IndyCar Series. To view the multimedia assets associated with this release, please click:...

2011-10-31 07:30:00

FRANKLIN LAKES, N.J., Oct. 31, 2011 /PRNewswire/ -- BD AutoShield(TM) Duo is a next generation, 5mm safety-engineered pen needle designed to protect healthcare workers from needlestick injuries and blood exposure. It is now available in the US from BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company. To view multimedia assets for this release, please click:...

2011-07-11 10:43:00

BOCA RATON, Fla., July 11, 2011 /PRNewswire/ -- American Scientific Resources, Inc. ("American Scientific Resources" or the "Company") (OTCQB: ASFX) and its distributor, School Health Corporation, today announced that they have received a purchase order from School Health Corporation for 108 Disintegrator Plus units to be delivered to a single school district to meet their needle disposal needs. (Logo: http://photos.prnewswire.com/prnh/20110124/NY34439LOGO ) The Disintegrator Plus(TM) is...

2011-06-27 00:00:00

PARIS, June 27, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus(R) and/or Apidra(R) with the insulin delivery device SoloSTAR(R) experienced greater treatment satisfaction, better quality of life and lower fear of hypoglycemia vs those using a premixed insulin product. The goal of the...

2011-06-07 07:00:00

BRIDGEWATER, N.J., June 7, 2011 /PRNewswire/ -- Actors Paul and Mira Sorvino today announce the Diabetes Co-Stars: Cook-Off. This nationwide recipe contest runs from June 7-July 20, 2011 and is a continuation of their work with sanofi-aventis U.S. on the Diabetes Co-Stars awareness campaign, which is designed to help educate people living with diabetes and those who support them. To view the multimedia assets associated with this release, please click:...

2011-03-24 06:00:00

ST. PETERSBURG, Fla., March 24, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, is partnering with 2011 IZOD IndyCar Series driver Charlie Kimball to launch the educational program, Drive the Switch, encouraging diabetes patients who use insulin and caregivers to pledge to talk to their health care professional about options for insulin delivery, like the prefilled insulin pen device. Nearly 90 years since the discovery of insulin, Americans still have not embraced...

2011-01-19 06:00:00

CRAWLEY, England, January 19, 2011 /PRNewswire/ -- A 2010 GOOD DESIGN(TM) Award[1] has been awarded to Novo Nordisk for NovoPen Echo(R), the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives. More than 400,000 children are diagnosed with Type 1 diabetes worldwide[2] and these children may need to inject themselves multiple...

2010-10-04 09:45:00

PRINCETON, N.J., Oct. 4 /PRNewswire/ -- Novo Nordisk, a global healthcare company and leader in diabetes care, today announced a $73 million expansion of its Clayton, NC manufacturing facility to accommodate increased production capacity for the Company's insulin delivery devices. The initial expansion will create 205 new jobs, including 85 in the Novo Nordisk Clayton facility, which currently produces a number of products, including the Levemir®...